Mindray Announces Registration of the BS-200 and BS-480 Chemistry Analyzers with Health Canada

Mindray announced that it has received a Medical Device License (#94555) from Health Canada to market and sell the Mindray BS-200 Chemistry Analyzer and the Mindray BS-480 Chemistry Analyzer into the Canadian laboratory market.

The Mindray BS-200 Chemistry Analyzer is a bench top system offering state-of-the art features commonly found on large volume analyzers. It produces 200 photometric test results per hour and 330 tests per hour with electrolytes. A comprehensive chemistry and urine drugs of abuse screening menu is a perfect low cost solution for low to mid volume laboratories.

The Mindray BS-480 Chemistry Analyzer meets the testing needs of mid-volume laboratories producing 400 photometric test results per hour, 240 electrolyte tests per hour with an overall throughput of 560 tests per hour. Advanced features of the BS-480 analyzer include numerous automatic processes such as Auto-Start-Up, -QC, -Rerun, -Pre-dilution, -Post-dilution, -ISE Calibration, -Probe Cleaning, -Reagent Blank Checks and -Probe Collision Recovery which provides the laboratory with smooth operational and enhanced workflow efficiencies. The BS-480 analyzer will feature a broad chemistry and urine drugs of abuse test menu including Vitamin D, currently in development.

Finn Li, Ph.D., General Manager of Mindray IVD North America, stated: “We are excited to launch the BS-200 and the BS-480 analyzers into the Canadian laboratory market. Mindray enjoys satisfied customer experiences with these analyzers and looks forward to adding Canadian customers to our installed base.

MedTest is the exclusive US distributor of the BS-200 and the BS-480 Chemistry Analyzers including manufacturing and distribution of reagents, calibrators and quality control products for the general chemistry and drugs of abuse testing markets. The BS-200 and BS-480 Chemistry Analyzers and reagents will be exclusively sold in Canada by Clinitox Diagnostix, a MedTest Company. Hanjoon Ryu, CEO of MedTest, stated: “Canadian laboratories deserve an integrated service provider who offers innovative instruments with proven quality reagents, superior customer support and recognized economic advantages. Clinitox Diagnostix, a MedTest Company, is delighted to share this announcement with our strategic partner, Mindray.”